These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30948167)

  • 81. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
    Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
    Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical metabolomics paves the way towards future healthcare strategies.
    Collino S; Martin FP; Rezzi S
    Br J Clin Pharmacol; 2013 Mar; 75(3):619-29. PubMed ID: 22348240
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Metabolomics Analyses from Tissues in Parkinson's Disease.
    Bhinderwala F; Lei S; Woods J; Rose J; Marshall DD; Riekeberg E; Leite AL; Morton M; Dodds ED; Franco R; Powers R
    Methods Mol Biol; 2019; 1996():217-257. PubMed ID: 31127560
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients.
    Weiner J; Parida SK; Maertzdorf J; Black GF; Repsilber D; Telaar A; Mohney RP; Arndt-Sullivan C; Ganoza CA; Faé KC; Walzl G; Kaufmann SH
    PLoS One; 2012; 7(7):e40221. PubMed ID: 22844400
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Statistical methods and resources for biomarker discovery using metabolomics.
    Anwardeen NR; Diboun I; Mokrab Y; Althani AA; Elrayess MA
    BMC Bioinformatics; 2023 Jun; 24(1):250. PubMed ID: 37322419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.
    Rankin NJ; Preiss D; Welsh P; Sattar N
    Int J Epidemiol; 2016 Oct; 45(5):1351-1371. PubMed ID: 27789671
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort.
    Conde R; Laires R; Gonçalves LG; Rizvi A; Barroso C; Villar M; Macedo R; Simões MJ; Gaddam S; Lamosa P; Puchades-Carrasco L; Pineda-Lucena A; Patel AB; Mande SC; Banerjee S; Matzapetakis M; Coelho AV
    Biomed J; 2022 Aug; 45(4):654-664. PubMed ID: 34314900
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research.
    Lv H; Jiang F; Guan D; Lu C; Guo B; Chan C; Peng S; Liu B; Guo W; Zhu H; Xu X; Lu A; Zhang G
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918446
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Metabolomics for Animal Models of Rare Human Diseases: An Expert Review and Lessons Learned.
    Kilk K
    OMICS; 2019 Jun; 23(6):300-307. PubMed ID: 31120384
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Omics Biomarkers for Monitoring Tuberculosis Treatment: A Mini-Review of Recent Insights and Future Approaches.
    Pitaloka DAE; Syamsunarno MRAAA; Abdulah R; Chaidir L
    Infect Drug Resist; 2022; 15():2703-2711. PubMed ID: 35664683
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets.
    Wettersten HI; Weiss RH
    Organogenesis; 2013; 9(1):11-8. PubMed ID: 23538740
    [TBL] [Abstract][Full Text] [Related]  

  • 92. ABA-Cloud: support for collaborative breath research.
    Elsayed I; Ludescher T; King J; Ager C; Trosin M; Senocak U; Brezany P; Feilhauer T; Amann A
    J Breath Res; 2013 Jun; 7(2):026007. PubMed ID: 23619467
    [TBL] [Abstract][Full Text] [Related]  

  • 93. How far are we from reliable metabolomics-based biomarkers? The often-overlooked importance of addressing inter-individual variability factors.
    González-Domínguez Á; González-Domínguez R
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166910. PubMed ID: 37802155
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Method/ology of Phases of Biomarker Discovery.
    Navanandan N; Searns J; Ambroggio L
    Hosp Pediatr; 2023 Jul; 13(7):e181-e185. PubMed ID: 37317806
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Important Considerations for Sample Collection in Metabolomics Studies with a Special Focus on Applications to Liver Functions.
    Smith L; Villaret-Cazadamont J; Claus SP; Canlet C; Guillou H; Cabaton NJ; Ellero-Simatos S
    Metabolites; 2020 Mar; 10(3):. PubMed ID: 32178364
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Statistical methods for the analysis of high-throughput metabolomics data.
    Bartel J; Krumsiek J; Theis FJ
    Comput Struct Biotechnol J; 2013; 4():e201301009. PubMed ID: 24688690
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metabolomics and biomarkers in ocular matrix: beyond ocular diseases.
    Luo Y; Cui HP; Liu Y; Chen L
    Int J Ophthalmol; 2020; 13(6):991-1003. PubMed ID: 32566514
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Blood transcriptional signatures for tuberculosis testing.
    Mendelsohn SC; Mbandi SK; Hatherill M; Scriba TJ
    Lancet Respir Med; 2020 Apr; 8(4):330-331. PubMed ID: 32178777
    [No Abstract]   [Full Text] [Related]  

  • 99. Metabolomics, the future of biomarkers?
    Occelli C; Levraut J; Pourcher T
    Eur J Emerg Med; 2024 Feb; 31(1):7-8. PubMed ID: 37988452
    [No Abstract]   [Full Text] [Related]  

  • 100. Editorial.
    Bartlett MG
    Biomed Chromatogr; 2020 Jan; 34(1):e4764. PubMed ID: 31884691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.